Search - tctmd.com

Displaying 201 - 220 of 238

Sort: Relevancy | Date

Presentation THT 2023

Cardiogenic Shock: Customized Therapeutic Approaches in 2023

Presenter: A. Reshad Garan

March 20, 2023

Presentation THT 2023

Cardiogenic Shock: Patient Phenotyping and Prognostication

Presenter: Manreet Kanwar

March 20, 2023

Presentation THT 2023

Right Heart Failure with Preserved Ejection Fraction: A New Clinical Phenotype with Clinical and Prognostic Relevance

Presenter: Athiththan Yogeswaran

March 20, 2023

Presentation THT 2023

Clinical Outcomes for Patients with Obesity and High output heart failure: An Analysis of the National Inpatient Sample

Presenter: Rafail Beshai

March 20, 2023

Presentation THT 2023

Clinical Outcomes of Cardiac Devices in Heart Failure patients hospitalized with COVID-19: Insights from National Inpatient Sample Database

Presenter: Errol Moras

March 20, 2023

News Conference News THT 2022

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Caitlin E. Cox

February 07, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

Presentation THT 2022

Executing Clinical Follow Up In the Modern Era

Presenter: Jodi Akin

February 02, 2022

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

Presentation THT 2022

Clinical Trials During COVID-19: Innvestigator Perspective

Presenter: Scott Solomon

February 02, 2022

Presentation THT 2022

Research Consortium / Collabratories

Presenter: Mona Fiuzat

February 02, 2022

Presentation THT 2022

Challenges With Cardiogenic Shock Studies in the US

Presenter: Chuck Simonton

February 02, 2022

Presentation THT 2022

Innovation in Heart Failure Trial Designs

Presenter: Ori Ben-Yehuda

February 02, 2022

Presentation THT 2022

Heart Failure Trials in the Modern Era: Where Are We Going?

Presenter: Andrew Farb

February 02, 2022

Presentation THT 2022

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

Presenter: Akshay Desai

February 02, 2022

Presentation THT 2022

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Presenter: Sebastian Rosch

February 02, 2022

Presentation THT 2022

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

Presenter: Shashank Sinha

February 02, 2022

Presentation THT 2022

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Presenter: JoAnn Lindenfeld

February 02, 2022

Advertisement

Cardiogenic Shock: Customized Therapeutic Approaches in 2023

Cardiogenic Shock: Patient Phenotyping and Prognostication

Right Heart Failure with Preserved Ejection Fraction: A New Clinical Phenotype with Clinical and Prognostic Relevance

Clinical Outcomes for Patients with Obesity and High output heart failure: An Analysis of the National Inpatient Sample

Clinical Outcomes of Cardiac Devices in Heart Failure patients hospitalized with COVID-19: Insights from National Inpatient Sample Database

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

Executing Clinical Follow Up In the Modern Era

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Clinical Trials During COVID-19: Innvestigator Perspective

Research Consortium / Collabratories

Challenges With Cardiogenic Shock Studies in the US

Innovation in Heart Failure Trial Designs

Heart Failure Trials in the Modern Era: Where Are We Going?

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

SCAI Stage Across Hospitalization and the Association of Time to Max Escalation and In-hospital Mortality Among Cardiogenic Shock Patients

Interatrial Shunting in Chronic Heart Failure: Results From the RELIEVE-HF Roll-In Cohort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content